{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T17:23:46Z","timestamp":1783963426288,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hubei provincial Department of Education Scientific Research Program Young talents Project","award":["Z2024303"],"award-info":[{"award-number":["Z2024303"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"DOI":"10.1186\/s13018-026-06852-x","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:15:27Z","timestamp":1778170527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LncRNA GAS5 inhibits the remodeling of the tumor microenvironment by binding to miR-93-5p, thereby suppressing the development of osteosarcoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Tianbo","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafeng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyong","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireadeli","family":"Abulimiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"6852_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.12.024","volume":"500","author":"C Chen","year":"2021","unstructured":"Chen C, Xie L, Ren T, Huang Y, Xu J, Guo W. Immunotherapy for osteosarcoma: fundamental mechanism, rationale, and recent breakthroughs. Cancer Lett. 2021;500:1\u201310.","journal-title":"Cancer Lett"},{"key":"6852_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2217\/fon-2016-0261","volume":"13","author":"L Kager","year":"2017","unstructured":"Kager L, Tamamyan G, Bielack S. Novel insights and therapeutic interventions for pediatric osteosarcoma. Future Oncol. 2017;13:357\u201368.","journal-title":"Future Oncol"},{"key":"6852_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2021.103105","volume":"102","author":"F Sadoughi","year":"2021","unstructured":"Sadoughi F, Dana PM, Asemi Z, Yousefi B. DNA damage response and repair in osteosarcoma: defects, regulation and therapeutic implications. DNA Repair (Amst). 2021;102:103105.","journal-title":"DNA Repair (Amst)"},{"key":"6852_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40425-015-0067-z","volume":"3","author":"DM Lussier","year":"2015","unstructured":"Lussier DM, Johnson JL, Hingorani P, Blattman JN. Combination immunotherapy with alpha-CTLA-4 and alpha-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma. J Immunother Cancer. 2015;3:21.","journal-title":"J Immunother Cancer"},{"key":"6852_CR5","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/1873-3468.13387","volume":"593","author":"CL Chen","year":"2019","unstructured":"Chen CL, Zhang L, Jiao YR, Zhou Y, Ge QF, Li PC, et al. miR-134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP 1 and MMP 3 in vitro and in vivo. FEBS Lett. 2019;593:1089\u2013101.","journal-title":"FEBS Lett"},{"key":"6852_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27227","volume":"65","author":"MF Wedekind","year":"2018","unstructured":"Wedekind MF, Wagner LM, Cripe TP. Immunotherapy for osteosarcoma: where do we go from here? Pediatr Blood Cancer. 2018;65:e27227.","journal-title":"Pediatr Blood Cancer"},{"key":"6852_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13569-018-0102-1","volume":"8","author":"J Xu","year":"2018","unstructured":"Xu J, Xie L, Guo W. PDGF\/PDGFR effects in osteosarcoma and the \u201cadd-on\u201d strategy. Clin Sarcoma Res. 2018;8:1\u20139.","journal-title":"Clin Sarcoma Res"},{"key":"6852_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41413-023-00246-z","volume":"11","author":"H Tian","year":"2023","unstructured":"Tian H, Cao J, Li B, Nice EC, Mao H, Zhang Y, et al. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment. Bone Res. 2023;11:11.","journal-title":"Bone Res"},{"key":"6852_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541\u201350.","journal-title":"Nat Med"},{"key":"6852_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/MS9.0000000000004352","volume":"88","author":"EI Obeagu","year":"2026","unstructured":"Obeagu EI. Inflammation, immunity, and invasion: the pivotal role of cytokine storms in cervical carcinogenesis. Ann Med Surg (Lond). 2026;88:492\u20139.","journal-title":"Ann Med Surg (Lond)"},{"key":"6852_CR11","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2023.04.025","volume":"186","author":"KC Barnett","year":"2023","unstructured":"Barnett KC, Li S, Liang K, Ting JP. A 360 degrees view of the inflammasome: mechanisms of activation, cell death, and diseases. Cell. 2023;186:2288\u2013312.","journal-title":"Cell"},{"key":"6852_CR12","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1038\/s41467-026-69546-2","volume":"17","author":"Z Zhang","year":"2026","unstructured":"Zhang Z, Li X, Lu T, Yang J, Han X, Bi Z, et al. Deficiency of lysosomal TMEM175 in myeloid macrophages exerts anti-tumor immunity via inflammasome and cross-presentation pathway. Nat Commun. 2026;17:2770.","journal-title":"Nat Commun"},{"key":"6852_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12672-025-04381-3","volume":"17","author":"J Zhang","year":"2026","unstructured":"Zhang J, Pang Y. Ubiquitin-specific protease 19 promotes M2 macrophage polarization and ovarian cancer progression via NLRP3 suppression. Discov Oncol. 2026;17:243.","journal-title":"Discov Oncol"},{"key":"6852_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00018-025-05966-5","volume":"82","author":"A Mortellaro","year":"2025","unstructured":"Mortellaro A, Mastaglio S, Muzio M. IL-1 signaling and inflammasomes in acute myeloid leukemia: mechanisms and therapeutic opportunities. Cell Mol Life Sci. 2025;82:443.","journal-title":"Cell Mol Life Sci"},{"key":"6852_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/bmb\/ldaa002","volume":"133","author":"L Giordano","year":"2020","unstructured":"Giordano L, Porta GD, Peretti GM, Maffulli N. Therapeutic potential of microRNA in tendon injuries. Br Med Bull. 2020;133:79\u201394.","journal-title":"Br Med Bull"},{"key":"6852_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/bmb\/ldz015","volume":"130","author":"A Oliviero","year":"2019","unstructured":"Oliviero A, Porta GD, Peretti GM, Maffulli N. MicroRNA in osteoarthritis: physiopathology, diagnosis and therapeutic challenge. Br Med Bull. 2019;130:137\u201347.","journal-title":"Br Med Bull"},{"key":"6852_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/bmb\/ldaa040","volume":"138","author":"G Gargano","year":"2021","unstructured":"Gargano G, Oliviero A, Oliva F, Maffulli N. Small interfering RNAs in tendon homeostasis. Br Med Bull. 2021;138:58\u201367.","journal-title":"Br Med Bull"},{"key":"6852_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/bmb\/ldac012","volume":"142","author":"G Gargano","year":"2022","unstructured":"Gargano G, Oliva F, Oliviero A, Maffulli N. Small interfering RNAs in the management of human rheumatoid arthritis. Br Med Bull. 2022;142:34\u201343.","journal-title":"Br Med Bull"},{"key":"6852_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/bmb\/ldad023","volume":"148","author":"G Gargano","year":"2023","unstructured":"Gargano G, Asparago G, Spiezia F, Oliva F, Maffulli N. Small interfering RNAs in the management of human osteoporosis. Br Med Bull. 2023;148:58\u201369.","journal-title":"Br Med Bull"},{"key":"6852_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldae024","volume":"153","author":"G Gargano","year":"2025","unstructured":"Gargano G, Pagano SM, Maffulli N. Circular RNAs in the management of human osteoporosis. Br Med Bull. 2025;153:ldae024.","journal-title":"Br Med Bull"},{"key":"6852_CR21","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1186\/s13018-025-06001-w","volume":"20","author":"X Yang","year":"2025","unstructured":"Yang X, Jin Q, Guo L. MiR-217 participates in the progression of postmenopausal osteoporosis by regulating the OPG\/RANKL\/RANK pathway. J Orthop Surg Res. 2025;20:600.","journal-title":"J Orthop Surg Res"},{"key":"6852_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-025-05999-3","volume":"20","author":"C Zhao","year":"2025","unstructured":"Zhao C, Li Q, Shen C. Therapeutic potential of miR-204-5p in intervertebral disc degeneration: targeting the SSRP1\/NF-kappaB pathway to inhibit apoptosis. J Orthop Surg Res. 2025;20:586.","journal-title":"J Orthop Surg Res"},{"key":"6852_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-025-05943-5","volume":"20","author":"Y Li","year":"2025","unstructured":"Li Y, Ye S, Han Z, Wei C, Huang Y. LncRNA CRNDE ameliorates bone fracture by regulating cell viability and apoptosis of osteoblasts. J Orthop Surg Res. 2025;20:521.","journal-title":"J Orthop Surg Res"},{"key":"6852_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-025-05810-3","volume":"20","author":"F Li","year":"2025","unstructured":"Li F, Tan H, Zhang X, Zhao X, Li X, Chen G. LncRNA HCG18 regulates the progression of spinal tuberculosis by modulating the hsa-miR-146a-5p\/TGF-beta1\/SMADs pathway. J Orthop Surg Res. 2025;20:484.","journal-title":"J Orthop Surg Res"},{"key":"6852_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13473-w","volume":"25","author":"S Ying","year":"2025","unstructured":"Ying S, Wu N, Ruan Y, Ge W, Ma P, Xu T, et al. IL-17 triggers PD-L1 gene transcription in NSCLC cells via TRIM31-dependent MEF2C K63-linked polyubiquitination. BMC Cancer. 2025;25:81.","journal-title":"BMC Cancer"},{"key":"6852_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41420-025-02626-2","volume":"11","author":"X Lu","year":"2025","unstructured":"Lu X, Zhang X, Zhang F, Wang W, Liu R, Hou Y, et al. SPON2 facilitates osteosarcoma development by inducing M2 macrophage polarization through activation of the NF-kappaB\/VEGF signaling axis. Cell Death Discov. 2025;11:352.","journal-title":"Cell Death Discov"},{"key":"6852_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-025-06059-6","volume":"20","author":"X Yang","year":"2025","unstructured":"Yang X, Yin P, Yao X, Zhang J. MicroRNAs in the diagnosis of osteoarthritis: a systematic review and meta-analysis of observational studies. J Orthop Surg Res. 2025;20:654.","journal-title":"J Orthop Surg Res"},{"key":"6852_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12974-025-03551-y","volume":"22","author":"H Liang","year":"2025","unstructured":"Liang H, Yang Q, Zhong B, Li D, Wu F, Zhang J, et al. IL-1beta(+) tumor-associated macrophages accelerate glioblastoma progression by amplifying the PGE2-EP4 signaling. J Neuroinflammation. 2025;22:233.","journal-title":"J Neuroinflammation"},{"key":"6852_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-020-0167-x","volume":"6","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E. Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov. 2020;6:36.","journal-title":"Cell Discov"},{"key":"6852_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-025-05872-3","volume":"20","author":"X Liu","year":"2025","unstructured":"Liu X, Zhang X, Cen M. Dysregulation of miR-106a-5p\/PTEN axis associated with progression and diagnostic of postmenopausal osteoporosis. J Orthop Surg Res. 2025;20:456.","journal-title":"J Orthop Surg Res"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-026-06852-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-026-06852-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-026-06852-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T17:02:09Z","timestamp":1783962129000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13018-026-06852-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6852"],"URL":"https:\/\/doi.org\/10.1186\/s13018-026-06852-x","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"23 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board approved the protocol for this study (No. RHLL-2025\u201301), and written informed consent was obtained from all participants or their legal guardians in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was not needed, as this study did not include any identifiable personal or clinical details of the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"395"}}